Interestingly, RNAi-mediated ablation of BCL3 (B-cell CLL/Lymphoma 3) expression in activated fibroblasts, leads to a strong decrease of ICAM-1 expression both in LIF-activated fibroblasts and in CAF (data not shown). This evidence concerns the gene BCL3 and B-cell chronic lymphocytic leukemia.